FDA.reportPublic FDA data

golimumab 50 MG in 0.5 ML Prefilled Syringe

RxCUI
848160
RxNorm name
golimumab 50 MG in 0.5 ML Prefilled Syringe
Display name
golimumab 50 MG in 0.5 ML Prefilled Syringe
Full name
golimumab 50 MG in 0.5 ML Prefilled Syringe
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125289Simponigolimumab351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f86cb4a7-c358-4136-ae57-b32bda9bba00golimumab 50 MG in 0.5 ML Prefilled Syringe [PSN] · 0.5 ML golimumab 100 MG/ML Prefilled Syringe [SCD] · golimumab 50 MG per 0.5 ML Prefilled Syringe [SY]342These highlights do not include all the information needed to use SIMPONI safely and effectively. See full prescribing information for SIMPONI. SIMPONI ® (golimumab) injection, for subcutaneous use Initial U.S. Approval: 200920251029